Core Capital Management & Research, inc.’s Pfizer PFE Stock Holding History

Core Capital Management & Research, inc.’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.46M	Buy	+194,623	New	+$5.09M	2.87%	13

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Core Capital Management & Research, inc.'s PFE Position: Q2 2026 in Review

Core Capital Management & Research, inc. opened a new position in Pfizer (PFE) in Q2 2026: 194,623 shares worth $5.46M. The stake represents 2.87% of the portfolio and ranks #13 among its holdings.

2,828 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Core Capital Management & Research, inc. held 194,623 shares of Pfizer worth $5.46M as of Q2 2026.
Pfizer was a new Core Capital Management & Research, inc. position in Q2 2026.
Pfizer made up 2.87% of Core Capital Management & Research, inc.'s portfolio in Q2 2026, its #13 holding.
2,828 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Core Capital Management & Research, inc.'s 13F filing for Q2 2026, filed 9 Sep 2026.